136 related articles for article (PubMed ID: 17348854)
1. A quantitative structure-activity relationship study on some novel series of hydroxamic acid analogs acting as matrix metalloproteinase inhibitors.
Kumaran S; Gupta SP
Med Chem; 2007 Mar; 3(2):167-73. PubMed ID: 17348854
[TBL] [Abstract][Full Text] [Related]
2. A quantitative structure-activity relationship study on matrix metalloproteinase inhibitors: piperidine sulfonamide aryl hydroxamic acid analogs.
Kumaran S; Gupta SP
J Enzyme Inhib Med Chem; 2007 Feb; 22(1):23-7. PubMed ID: 17373543
[TBL] [Abstract][Full Text] [Related]
3. Quantitative structure-activity relationship studies on matrix metalloproteinase inhibitors: hydroxamic acid analogs.
Gupta SP; Kumaran S
Med Chem; 2006 May; 2(3):243-50. PubMed ID: 16948470
[TBL] [Abstract][Full Text] [Related]
4. Heteroaryl and cycloalkyl sulfonamide hydroxamic acid inhibitors of matrix metalloproteinases.
Levin JI; Gu Y; Nelson FC; Zask A; DiJoseph JF; Sharr MA; Sung A; Jin G; Cowling R; Chanda P; Cosmi S; Hsiao CL; Edris W; Wilhelm J; Killar LM; Skotnicki JS
Bioorg Med Chem Lett; 2001 Jan; 11(2):239-42. PubMed ID: 11206468
[TBL] [Abstract][Full Text] [Related]
5. The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.
Steinman DH; Curtin ML; Garland RB; Davidsen SK; Heyman HR; Holms JH; Albert DH; Magoc TJ; Nagy IB; Marcotte PA; Li J; Morgan DW; Hutchins C; Summers JB
Bioorg Med Chem Lett; 1998 Aug; 8(16):2087-92. PubMed ID: 9873491
[TBL] [Abstract][Full Text] [Related]
6. MMPs inhibitors: new succinylhydroxamates with selective inhibition of MMP-2 over MMP-3.
Marcq V; Mirand C; Decarme M; Emonard H; Hornebeck W
Bioorg Med Chem Lett; 2003 Sep; 13(17):2843-6. PubMed ID: 14611841
[TBL] [Abstract][Full Text] [Related]
7. Discovery of potent and selective succinyl hydroxamate inhibitors of matrix metalloprotease-3 (stromelysin-1).
Fray MJ; Dickinson RP
Bioorg Med Chem Lett; 2001 Feb; 11(4):571-4. PubMed ID: 11229774
[TBL] [Abstract][Full Text] [Related]
8. Selectivity of inhibition of matrix metalloproteases MMP-3 and MMP-2 by succinyl hydroxamates and their carboxylic acid analogues is dependent on P3' group chirality.
Fray MJ; Burslem MF; Dickinson RP
Bioorg Med Chem Lett; 2001 Feb; 11(4):567-70. PubMed ID: 11229773
[TBL] [Abstract][Full Text] [Related]
9. A novel series of highly selective inhibitors of MMP-3.
Whitlock GA; Dack KN; Dickinson RP; Lewis ML
Bioorg Med Chem Lett; 2007 Dec; 17(24):6750-3. PubMed ID: 18029177
[TBL] [Abstract][Full Text] [Related]
10. The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position.
Levin JI; Du MT; DiJoseph JF; Killar LM; Sung A; Walter T; Sharr MA; Roth CE; Moy FJ; Powers R; Jin G; Cowling R; Skotnicki JS
Bioorg Med Chem Lett; 2001 Jan; 11(2):235-8. PubMed ID: 11206467
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.
Pikul S; McDow Dunham KL; Almstead NG; De B; Natchus MG; Anastasio MV; McPhail SJ; Snider CE; Taiwo YO; Chen L; Dunaway CM; Gu F; Mieling GE
J Med Chem; 1999 Jan; 42(1):87-94. PubMed ID: 9888835
[TBL] [Abstract][Full Text] [Related]
12. The design and synthesis of aryl hydroxamic acid inhibitors of MMPs and TACE.
Levin JI
Curr Top Med Chem; 2004; 4(12):1289-310. PubMed ID: 15320727
[TBL] [Abstract][Full Text] [Related]
13. Sulfonate ester hydroxamic acids as potent and selective inhibitors of TACE enzyme.
Levin JI; Du MT
Drug Des Discov; 2003; 18(4):123-6. PubMed ID: 15553924
[TBL] [Abstract][Full Text] [Related]
14. Potent and selective aggrecanase inhibitors containing cyclic P1 substituents.
Cherney RJ; Mo R; Meyer DT; Wang L; Yao W; Wasserman ZR; Liu RQ; Covington MB; Tortorella MD; Arner EC; Qian M; Christ DD; Trzaskos JM; Newton RC; Magolda RL; Decicco CP
Bioorg Med Chem Lett; 2003 Apr; 13(7):1297-300. PubMed ID: 12657268
[TBL] [Abstract][Full Text] [Related]
15. A quantitative structure-activity relationship study on some matrix metalloproteinase and collagenase inhibitors.
Kumar D; Gupta SP
Bioorg Med Chem; 2003 Feb; 11(3):421-6. PubMed ID: 12517437
[TBL] [Abstract][Full Text] [Related]
16. Novel inhibitors of procollagen C-proteinase. Part 2: glutamic acid hydroxamates.
Robinson LA; Wilson DM; Delaet NG; Bradley EK; Dankwardt SM; Campbell JA; Martin RL; Van Wart HE; Walker KA; Sullivan RW
Bioorg Med Chem Lett; 2003 Jul; 13(14):2381-4. PubMed ID: 12824039
[TBL] [Abstract][Full Text] [Related]
17. N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.
Nuti E; Casalini F; Avramova SI; Santamaria S; Cercignani G; Marinelli L; La Pietra V; Novellino E; Orlandini E; Nencetti S; Tuccinardi T; Martinelli A; Lim NH; Visse R; Nagase H; Rossello A
J Med Chem; 2009 Aug; 52(15):4757-73. PubMed ID: 19606871
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design and synthesis of a series of hydroxamic acids with a quaternary-hydroxy group in P1 as inhibitors of matrix metalloproteinases.
Jacobson IC; Reddy PG; Wasserman ZR; Hardman KD; Covington MB; Arner EC; Copeland RA; Decicco CP; Magolda RL
Bioorg Med Chem Lett; 1998 Apr; 8(7):837-42. PubMed ID: 9871551
[TBL] [Abstract][Full Text] [Related]
19. Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3.
Reiter LA; Mitchell PG; Martinelli GJ; Lopresti-Morrow LL; Yocum SA; Eskra JD
Bioorg Med Chem Lett; 2003 Jul; 13(14):2331-6. PubMed ID: 12824028
[TBL] [Abstract][Full Text] [Related]
20. The synthesis and biological activity of a novel series of diazepine MMP inhibitors.
Levin JI; DiJoseph JF; Killar LM; Sung A; Walter T; Sharr MA; Roth CE; Skotnicki JS; Albright JD
Bioorg Med Chem Lett; 1998 Oct; 8(19):2657-62. PubMed ID: 9873598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
